Cargando…

TCF-1 participates in the occurrence of dedifferentiated chondrosarcoma

The present study demonstrated that T cell factor 1 (TCF-1) protein, a component of the canonical Wnt/β-catenin signaling pathway, can regulate the expression of runt-related transcription factor 2 (runx2) gene and Sry-related HMG box 9 (sox9) gene, which may participate in the differentiation of ch...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Xiaolong, Tang, Xiaodong, Guo, Wei, Yang, Kang, Ren, Tingting
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5097086/ https://www.ncbi.nlm.nih.gov/pubmed/27522523 http://dx.doi.org/10.1007/s13277-016-5235-3

Ejemplares similares

The molecular pathogenesis of dedifferentiated chondrosarcoma
por: Sakamoto, Akio
Publicado: (2014)

Putative Multifunctional Signature of Lung Metastases in Dedifferentiated Chondrosarcoma
por: Malchenko, Sergey, et al.
Publicado: (2012)

C‐reactive protein: An independent predictor for dedifferentiated chondrosarcoma
por: Nemecek, Elena, et al.
Publicado: (2018)

Three new chondrosarcoma cell lines: one grade III conventional central chondrosarcoma and two dedifferentiated chondrosarcomas of bone
por: van Oosterwijk, Jolieke G, et al.
Publicado: (2012)

Dedifferentiated chondrosarcoma of the cervical spine: a case report
por: Matsumoto, Yoshihiro, et al.
Publicado: (2013)

Dedifferentiated Peripheral Chondrosarcoma: A Review of Radiologic Characteristics
por: Henderson, Eric R., et al.
Publicado: (2013)

Dedifferentiated chondrosarcoma of the pelvis: clinical outcomes and current treatment
por: Lex, Johnathan R., et al.
Publicado: (2018)

Association of Preoperative Neutrophil/Lymphocyte Ratio with Clinical Outcomes in Dedifferentiated Chondrosarcoma Patients
por: Liu, Chenglei, et al.
Publicado: (2020)

Metastatic Dedifferentiated Chondrosarcoma to Thyroid Gland: A Case Report
por: Aladily, Tariq N., et al.
Publicado: (2021)

Establishment and Characterization of a Novel Dedifferentiated Chondrosarcoma Cell Line DDCS2
por: Li, Xiaoyang, et al.
Publicado: (2021)

Dedifferentiated chondrosarcoma: Radiological features, prognostic factors and survival statistics in 23 patients
por: Liu, Chenglei, et al.
Publicado: (2017)

Massive dedifferentiated chondrosarcoma affecting whole mandible with high recurrence potential
por: Mishra, Niranjan, et al.
Publicado: (2015)

Dedifferentiated Chondrosarcoma from Molecular Pathology to Current Treatment and Clinical Trials
por: Zając, Weronika, et al.
Publicado: (2023)

Dedifferentiated Central Chondrosarcoma: A Clinical, Histopathological, and Immunohistochemical Analysis of 57 Cases
por: Gong, Li-Hua, et al.
Publicado: (2021)

Distinct IDH1/2-associated Methylation Profile and Enrichment of TP53 and TERT Mutations Distinguish Dedifferentiated Chondrosarcoma from Conventional Chondrosarcoma
por: Dermawan, Josephine Kam Tai, et al.
Publicado: (2023)

Clonality analysis and IDH1 and IDH2 mutation detection in both components of dedifferentiated chondrosarcoma, implicated its monoclonal origin
por: Yang, Tingting, et al.
Publicado: (2020)

Clinical features and treatment outcomes of dedifferentiated and grade 3 chondrosarcoma: A multi‐institutional study
por: Kozawa, Eiji, et al.
Publicado: (2022)

Dedifferentiated Chondrosarcoma of Proximal Tibia and Fibula with an Infected Ulcer: A Case Report
por: Pattanashetty, O.B., et al.
Publicado: (2016)

Dedifferentiated chondrosarcoma with leukocytosis and elevation of serum G-CSF. A case report
por: Sakamoto, Akio, et al.
Publicado: (2006)

Appendicular dedifferentiated chondrosarcoma: A management and survival study from the SEER database
por: Gonzalez, Marcos R., et al.
Publicado: (2022)

A Retrospective Multi-Institutional Cohort Analysis of Clinical Characteristics and Outcomes in Dedifferentiated Chondrosarcoma
por: Bui, Nam, et al.
Publicado: (2023)

Proximal epithelioid sarcomatous dedifferentiation in secondary chondrosarcoma in a known case of multiple osteochondromatosis
por: Dey, Biswajit, et al.
Publicado: (2017)

Case report: Treatment of metastatic dedifferentiated chondrosarcoma with pembrolizumab yields sustained complete response
por: Singh, Amisha, et al.
Publicado: (2022)

Clinical outcome for patients with dedifferentiated chondrosarcoma: a report of 9 cases at a single institute
por: Yokota, Kazuya, et al.
Publicado: (2012)

Dedifferentiated chondrosarcoma of the middle finger arising from a solitary enchondroma: A case report
por: Yonezawa, Hirotaka, et al.
Publicado: (2022)

Pulmonary blastoma that was first diagnosed as dedifferentiated chondrosarcoma using medical thoracoscopy: A case report
por: Kim, Tae Hun, et al.
Publicado: (2022)

A Case Report and Brief Literature Review on Dedifferentiated Chondrosarcoma in Proximal Phalanx: A Rare Location
por: Desai, Ketav, et al.
Publicado: (2022)

Primary dedifferentiated chondrosarcoma of the lung with a 4-year history of breast cancer: A case report
por: Wen, Huan, et al.
Publicado: (2023)

Prognostic Factors in Dedifferentiated Chondrosarcoma: A Retrospective Analysis of a Large Series Treated at a Single Institution
por: Miao, Ruoyu, et al.
Publicado: (2019)

The immune landscape of chondrosarcoma reveals an immunosuppressive environment in the dedifferentiated subtypes and exposes CSFR1+ macrophages as a promising therapeutic target
por: Iseulys, Richert, et al.
Publicado: (2019)

Dedifferentiated Chondrosarcoma of the Rib Masquerading as a Giant Chest Wall Tumor in a Teenage Girl: An Unusual Presentation
por: Abraham, Viju Joseph, et al.
Publicado: (2014)

Differential expression of angiogenesis markers HSP70, HSP90, VEGF and pERK1/2 in both components of dedifferentiated chondrosarcomas
por: Schoedel, Karen, et al.
Publicado: (2021)

High TIL, HLA, and Immune Checkpoint Expression in Conventional High-Grade and Dedifferentiated Chondrosarcoma and Poor Clinical Course of the Disease
por: Nota, Sjoerd P. F. T., et al.
Publicado: (2021)

Differences in clinical characteristics and tumor prognosis between primary and secondary conventional pelvic chondrosarcoma
por: Zang, Jie, et al.
Publicado: (2020)

Apatinib for Treatment of Inoperable Metastatic or Locally Advanced Chondrosarcoma: What We Can Learn About the Biological Behavior of Chondrosarcoma from a Two-Center Study
por: Xie, Lu, et al.
Publicado: (2020)

Successful treatment of a dedifferentiated chondrosarcoma of the proximal humerus with a hemicortical articular surface sparing allograft: A case report
por: Gomez, Charles D., et al.
Publicado: (2020)

Retroperitoneal dedifferentiated liposarcoma with osteosarcomatous dedifferentiation
por: Nguyen, Vinh N., et al.
Publicado: (2015)

Myogenic dedifferentiation is associated with poor outcomes in retroperitoneal dedifferentiated liposarcomas
por: Dorian Yarih, Garcia-Ortega, et al.
Publicado: (2021)

Targeted next-generation sequencing of dedifferentiated chondrosarcoma in the skull base reveals combined TP53 and PTEN mutations with increased proliferation index, an implication for pathogenesis
por: Gao, Lu, et al.
Publicado: (2016)

Physiological oxygen tension reduces hepatocyte dedifferentiation in in vitro culture
por: Guo, Ren, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_m69bubc92qfhqm3v3eggtle1rs